-
1.发明授权
公开(公告)号：EP1283714B1
公开(公告)日：2006-07-05
申请号：EP01929743.1
申请日：2001-04-27
发明人： POSTAIRE, Eric , BONAVIDA, Benjamin
CPC分类号： C12R1/245 , A23C9/1234 , A23Y2220/17 , A61K35/747
摘要： The invention concerns the use of Lactobacillus casei in a composition for oral administration to enhance immunity specific to pathogenic micro-organisms. Said composition can in particular be a food or a food supplement.
-
2.发明公开
公开(公告)号：EP1283714A1
公开(公告)日：2003-02-19
申请号：EP01929743.1
申请日：2001-04-27
发明人： POSTAIRE, Eric , BONAVIDA, Benjamin
CPC分类号： C12R1/245 , A23C9/1234 , A23Y2220/17 , A61K35/747
摘要： The invention concerns the use of Lactobacillus casei in a composition for oral administration to enhance immunity specific to pathogenic micro-organisms. Said composition can in particular be a food or a food supplement.
-
公开(公告)号：EP1175221A2
公开(公告)日：2002-01-30
申请号：EP00925413.7
申请日：2000-05-05
发明人： ANTOINE, Jean-Michel , CAYUELA, Chantal , DEGIVRY, Marie-Christine , LATGE, Christian , POSTAIRE, Eric
CPC分类号： C12R1/46 , A23C9/1234 , A23C9/1238 , A23L29/065 , A61K35/744 , C12P1/04 , Y10S435/854 , Y10S435/885
摘要： The invention concerns lactic acid bacteria with anxiolytic properties and not inducing sedative effect. Said lactic acid bacteria are useful in particular for preparing foods or medicines.
-
4.发明授权
公开(公告)号：EP1131080B2
公开(公告)日：2011-06-15
申请号：EP99956072.5
申请日：1999-11-18
CPC分类号： A23C9/1234 , A23L33/135 , A23Y2220/17 , A23Y2240/00 , A23Y2300/00 , A61K35/747 , Y10S436/815 , Y10T436/100833 , Y10T436/17 , Y10T436/177692
摘要： The invention concerns lactic acid bacteria strains capable of regulating the production of NO and inflammatory cytokines by enterocytes, depending on the inflammatory condition of said enterocytes. Said strains can also be incorporated in food supplements such as fermented dairy products used for regulating inflammatory response and non-specific immunity.
-
5.发明公开
公开(公告)号：EP1131080A2
公开(公告)日：2001-09-12
申请号：EP99956072.5
申请日：1999-11-18
CPC分类号： A23C9/1234 , A23L33/135 , A23Y2220/17 , A23Y2240/00 , A23Y2300/00 , A61K35/747 , Y10S436/815 , Y10T436/100833 , Y10T436/17 , Y10T436/177692
摘要： The invention concerns lactic acid bacteria strains capable of regulating the production of NO and inflammatory cytokines by enterocytes, depending on the inflammatory condition of said enterocytes. Said strains can also be incorporated in food supplements such as fermented dairy products used for regulating inflammatory response and non-specific immunity.
-
公开(公告)号：EP1175221B1
公开(公告)日：2007-05-23
申请号：EP00925413.7
申请日：2000-05-05
发明人： ANTOINE, Jean-Michel , CAYUELA, Chantal , DEGIVRY, Marie-Christine , LATGE, Christian , POSTAIRE, Eric
CPC分类号： C12R1/46 , A23C9/1234 , A23C9/1238 , A23L29/065 , A61K35/744 , C12P1/04 , Y10S435/854 , Y10S435/885
摘要： The invention concerns lactic acid bacteria with anxiolytic properties and not inducing sedative effect. Said lactic acid bacteria are useful in particular for preparing foods or medicines.
-
7.发明授权
公开(公告)号：EP1131080B1
公开(公告)日：2003-09-10
申请号：EP99956072.5
申请日：1999-11-18
CPC分类号： A23C9/1234 , A23L33/135 , A23Y2220/17 , A23Y2240/00 , A23Y2300/00 , A61K35/747 , Y10S436/815 , Y10T436/100833 , Y10T436/17 , Y10T436/177692
摘要： The invention concerns lactic acid bacteria strains capable of regulating the production of NO and inflammatory cytokines by enterocytes, depending on the inflammatory condition of said enterocytes. Said strains can also be incorporated in food supplements such as fermented dairy products used for regulating inflammatory response and non-specific immunity.
-
8.发明授权USE OF LACTIC ACID BACTERIA IN THE PREPARATION OF FERMENTED MILKS FOR THE TREATMENT OF DEPRESSED IMMUNITY LEVELS 有权MILCHSAÜREBAKTERIEN的奶制品生产发酵免疫力降低等级的治疗
-
9.发明公开USE OF LACTIC ACID BACTERIA IN THE PREPARATION OF FERMENTED MILKS FOR THE TREATMENT OF DEPRESSED IMMUNITY LEVELS 有权MILCHSAÜREBAKTERIEN的奶制品生产发酵免疫力降低等级的治疗
公开(公告)号：EP1178730A2
公开(公告)日：2002-02-13
申请号：EP00935083.6
申请日：2000-05-05
CPC分类号： A23C9/1234
摘要： Use of lactic acid bacteria, e.g. Lactobacillus casei in the preparation of fermented milks for the treatment of temporarily depressed immunity levels in individuals subjected to physiological stress with a Lactobacillus casei content in excess of 1 x 105 c.f.u. per millilitre.
-
-
-
-
-
-
-
-
搜索结果
9 条记录 (耗时 0.012 秒)
